يعرض 1 - 10 نتائج من 13 نتيجة بحث عن '"Morgillo F."', وقت الاستعلام: 1.58s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II study.

    المؤلفون: Gridelli, C.1, Morgillo, F.2, Favaretto, A.3, de Marinis, F.4, Chella, A.5, Cerea, G.6, Mattioli, R.7, Tortora, G.8, Rossi, A.1, Fasano, M.2, Pasello, G.3, Ricciardi, S.4, Maione, P.1, Di Maio, M.9, Ciardiello, F.2

    المصدر: Annals of Oncology. Jul2011, Vol. 22 Issue 7, p1528-1534. 7p. 4 Charts, 1 Graph.

    مصطلحات موضوعية: *LUNG cancer treatment, *ENZYME inhibitors, *ANTINEOPLASTIC agents, *OLDER patients, *VASCULAR endothelial growth factors, *MEDICATION safety, *DISEASE progression, *RANDOMIZED controlled trials

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية
    Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy

    المؤلفون: Ciardiello, F., Troiani, T., Bianco, R., Orditura, M., Morgillo, F., Martinelli, E., Morelli, M.P., Cascone, T., Tortora, G.

    المصدر: Annals of Oncology; June 2006, Vol. 17 Issue: 1, Number 1 Supplement 7 pvii109-vii114, 6p

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    163P Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: Findings from the CAVE-lung trial.

    المؤلفون: Della Corte, C.M.1 (AUTHOR), Fasano, M.1 (AUTHOR), Ciaramella, V.1 (AUTHOR), Cimmino, F.1 (AUTHOR), Cardnell, R.2 (AUTHOR), Gay, C.M.2 (AUTHOR), Ramkumar, K.2 (AUTHOR), Diao, L.2 (AUTHOR), Di Liello, R.1 (AUTHOR), Viscardi, G.1 (AUTHOR), Famiglietti, V.1 (AUTHOR), Ciardiello, D.1 (AUTHOR), Martini, G.1 (AUTHOR), Napolitano, S.1 (AUTHOR), Troiani, T.1 (AUTHOR), Martinelli, E.1 (AUTHOR), Wang, J.2 (AUTHOR), Byers, L.2 (AUTHOR), Morgillo, F.1 (AUTHOR), Ciardiello, F.1 (AUTHOR)

    المصدر: Annals of Oncology. 2022 Supplement 2, Vol. 33, pS107-S108. 2p.

    مصطلحات موضوعية: *NON-small-cell lung carcinoma, *NATURAL immunity, *ANTINEOPLASTIC agents, *CETUXIMAB, *CANCER patients

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    1533P Atezolizumab (ATZ) plus carboplatin (Cb) and etoposide (eto) in patients with untreated extensive-stage small cell lung cancer (ES-SCLC): Results from the interim analysis of MAURIS trial.

    المؤلفون: Bria, E.1 (AUTHOR), Garassino, M.C.2 (AUTHOR), Del Signore, E.3 (AUTHOR), Morgillo, F.4 (AUTHOR), Spinnato, F.5 (AUTHOR), Morabito, A.6 (AUTHOR), Iero, M.7 (AUTHOR), Ardizzoni, A.8 (AUTHOR)

    المصدر: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1248-S1248. 1p.

    مصطلحات موضوعية: *SMALL cell lung cancer, *ATEZOLIZUMAB, *ETOPOSIDE, *CARBOPLATIN

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    1335P Anti-tumour efficacy of cetuximab plus avelumab in NSCLC through induction of ADCC: Final data from CAVE-lung trial.

    المؤلفون: Fasano, M.1 (AUTHOR), Della Corte, C.M.1 (AUTHOR), Di Liello, R.1 (AUTHOR), Barra, G.1 (AUTHOR), Cimmino, F.2 (AUTHOR), Sparano, F.1 (AUTHOR), Viscardi, G.1 (AUTHOR), Iacovino, M.L.1 (AUTHOR), Paragliola, F.1 (AUTHOR), Famiglietti, V.1 (AUTHOR), Ciaramella, V.1 (AUTHOR), Sforza, V.3 (AUTHOR), Morabito, A.4 (AUTHOR), Maiello, E.5 (AUTHOR), Ciardiello, F.6 (AUTHOR), Morgillo, F.6 (AUTHOR)

    المصدر: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS858-S859. 2p.

    مصطلحات موضوعية: *CETUXIMAB, *NON-small-cell lung carcinoma

    النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    1329P Immune checkpoint inhibitors in advanced NSCLC patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers in a real world experience.

    المؤلفون: Lobefaro, R.1 (AUTHOR), Viscardi, G.1 (AUTHOR), Di Liello, R.2 (AUTHOR), Massa, G.1 (AUTHOR), Iacovino, M.L.2 (AUTHOR), Sparano, F.2 (AUTHOR), Della Corte, C.M.2 (AUTHOR), Ferrara, R.1 (AUTHOR), Signorelli, D.1 (AUTHOR), Proto, C.1 (AUTHOR), Prelaj, A.1 (AUTHOR), Galli, G.1 (AUTHOR), De Toma, A.1 (AUTHOR), Brambilla, M.1 (AUTHOR), Ganzinelli, M.1 (AUTHOR), Trevisan, B.1 (AUTHOR), De Braud, F.G.M.3 (AUTHOR), Morgillo, F.2 (AUTHOR), Garassino, M.C.1 (AUTHOR), Lo Russo, G.1 (AUTHOR)

    المصدر: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS856-S857. 2p.

    مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *NON-small-cell lung carcinoma, *BIOMARKERS

    النص الكامل

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    3O Efficacy of the triple combination of Estrogen Receptor, CDK4/6 and PI3K pathway inhibitors in ex-vivo models of breast cancer.

    المؤلفون: Diana, A.1 (AUTHOR), Della Corte, C.M.1 (AUTHOR), Carlino, F.1 (AUTHOR), Ciaramella, V.1 (AUTHOR), Franzese, E.1 (AUTHOR), Centonze, S.1 (AUTHOR), Trovato, C.1 (AUTHOR), Vassallo, I.1 (AUTHOR), Iovino, F.2 (AUTHOR), Procaccini, E.3 (AUTHOR), Ciardiello, F.1 (AUTHOR), Morgillo, F.1 (AUTHOR), Orditura, M.1 (AUTHOR)

    المصدر: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS245-S246. 2p.

    مصطلحات موضوعية: *BREAST cancer, *ESTROGEN receptors, *PHOSPHATIDYLINOSITOL 3-kinases, *ESTROGEN

    النص الكامل

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    1830P Early deaths (ED) upon first-line immunecheckpoint inhibitors (ICI) alone or combined to other non-ICI drugs across solid cancers: A systematic review and meta-analysis.

    المؤلفون: Viscardi, G.1 (AUTHOR), Simeon, V.2 (AUTHOR), Massari, F.3 (AUTHOR), Alfieri, S.4 (AUTHOR), Lambertini, M.5 (AUTHOR), Imbimbo, M.6 (AUTHOR), Mollica, V.3 (AUTHOR), Rizzo, A.3 (AUTHOR), Comito, F.3 (AUTHOR), Lo Russo, G.7 (AUTHOR), Proto, C.7 (AUTHOR), Prelaj, A.7 (AUTHOR), Galli, G.7 (AUTHOR), De Toma, A.7 (AUTHOR), Tralongo, A.8 (AUTHOR), Cinquini, M.8 (AUTHOR), Morgillo, F.1 (AUTHOR), Garassino, M.C.C.9 (AUTHOR), Torri, V.8 (AUTHOR), Ferrara, R.7 (AUTHOR)

    المصدر: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS1239-S1239. 1p.

    مصطلحات موضوعية: *EARLY death, *CANCER, *DRUGS

    النص الكامل

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    66P - Dual inhibition of TGF-β and AXL as a novel treatment for colorectal cancer.

    المؤلفون: Ciardiello, D.1 (AUTHOR), Belli, V.1 (AUTHOR), Cardone, C.1 (AUTHOR), Vitiello, P.P.1 (AUTHOR), Martini, G.1 (AUTHOR), Poliero, L.1 (AUTHOR), Borrelli, C.1 (AUTHOR), Arrichiello, G.1 (AUTHOR), Ciaramella, V.1 (AUTHOR), Matrone, N.1 (AUTHOR), Barra, G.1 (AUTHOR), De Falco, V.1 (AUTHOR), Giunta, E.F.1 (AUTHOR), Morgillo, F.1 (AUTHOR), Troiani, T.1 (AUTHOR), Terminiello, M.1 (AUTHOR), Melisi, D.2 (AUTHOR), Ciardiello, F.1 (AUTHOR), Martinelli, E.1 (AUTHOR)

    المصدر: Annals of Oncology. 2019 Supplement 6, Vol. 30, pv18-v19. 2p.

    مصطلحات موضوعية: *COLORECTAL cancer, *EPITHELIAL-mesenchymal transition, *TRANSFORMING growth factors, *CELLULAR signal transduction, *GENE expression profiling, *GROWTH factors

    النص الكامل

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    17P Genomic profiling of non-oncogene-addicted aNSCLC using liquid biopsy. A single institution Italian experience.

    المؤلفون: Liello, R Di1 (AUTHOR), Viscardi, G1 (AUTHOR), Sparano, F1 (AUTHOR), Corte, C M Della1 (AUTHOR), Iacovino, M L1 (AUTHOR), Paragliola, F1 (AUTHOR), Famiglietti, V1 (AUTHOR), Liello, A Di1 (AUTHOR), Ciardiello, F1 (AUTHOR), Morgillo, F1 (AUTHOR)

    المصدر: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *EPIDERMAL growth factor receptors, *PROTEIN-tyrosine kinases, *SQUAMOUS cell carcinoma

    الشركة/الكيان: ASTRAZENECA PLC AZN

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث